Intl Flavors & Fragrances Inc (IFF) reported a strong start to 2026, achieving revenue of over $2.7 billion in the first quarter, marking a 3% increase compared to the previous year. This growth was primarily driven by volume improvements across all business segments, with the health and biosciences sector leading the way with a 5% sales increase. The company's adjusted EBITDA reached $568 million, reflecting an 8% increase, supported by productivity gains and a focus on cash flow management. IFF completed the divestiture of its commodity soy crush concentrates and lecithin business for $110 million and is making progress in selling its food ingredients business. Despite facing challenges from the ongoing conflict in the Middle East, IFF remains optimistic, reaffirming its full-year sales guidance of $10.5 billion to $10.8 billion and an adjusted EBITDA growth of 3% to 8%. Management emphasized their commitment to innovation and productivity to navigate inflationary pressures and ensure long-term success.